SCHEMBL8933871

SCHEMBL8933871

Cc1ccc2c(c1)COc1c(C(F)F)nn(-c3ccc(S(N)(=O)=O)cc3)c1-2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.52
PTGS1 P23219 9/20 0.52
PTGES O14684 2/20 0.42
CA1 P00915 4/20 0.41
CA2 P00918 4/20 0.41
CA9 Q16790 4/20 0.41
CA12 O43570 3/20 0.41
HDAC3 O15379 1/20 0.40
PDPK1 O15530 1/20 0.40
PDE5A O76074 1/20 0.40
ABCB11 O95342 1/20 0.40
MT-CO2 P00403 1/20 0.40
LMNA P02545 1/20 0.40
CA3 P07451 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX5 P09917 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
ADRB3 P13945 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8933831 0.84 PTGS2 (0.67) PTGS2PTGS1PTGESCA1CA2
SCHEMBL6410104 0.82 PTGS2 (0.54) PTGS2PTGS1PTGESCA1CA2
SCHEMBL8933926 0.80 PTGS2 (0.73) PTGS2PTGS1CA1CA2CA9
SCHEMBL8933928 0.73 PTGS2 (0.67) PTGS2PTGS1
SCHEMBL8933854 0.73 PTGS2 (0.69) PTGS2PTGS1CA1CA2CA9
SCHEMBL8934192 0.72 PTGS2 (0.56) PTGS2PTGS1PDPK1
SCHEMBL8735027 0.72 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL8934174 0.72 PTGS2 (0.64) PTGS2PTGS1ABCB11
SCHEMBL8765285 0.71 PTGS2 (0.60) PTGS2PTGS1PTGESCA1CA2
SCHEMBL6344383 0.71 PTGS2 (0.56) PTGS2PTGS1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996009304-A1 BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-28 WO claimed
WO-1996009304-A1 BENZOPYRANOPYRAZOLYL DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-28 WO disclosed